{
  "report_rows": [
    {
      "kpi": "Pro forma adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.24 vs. cons $1.21",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Pro forma revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$706M vs. cons $703M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Pro forma organic revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~3.2% vs. cons 2.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 pro forma organic growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.5% vs. cons 3.5% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 pro forma revenue",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.825B vs. cons $2.825B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 pro forma adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$5.25 vs. cons $5.26 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 pro forma adjusted operating margin",
      "prediction": "UNCHANGED",
      "answer": "guide ~28.4% vs. cons 28.4% (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.0,
  "day5_path": "STABILIZE",
  "day5_rationale": "A modest Q2 EPS/organic-growth beat should support an initial ~2.0% residual move, but unchanged FY2026 revenue, EPS, growth, and margin guidance leaves out-period estimates near ~$5.25 versus ~$5.26 consensus; absent a guide raise, revisions should be limited and the initial reaction should stabilize toward ~1.0% by day five.",
  "day5_confidence": "MEDIUM"
}